Article
HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B*57:01 genotyping to predict abacavir hypersensitivity reaction in Spain.
Pharmacogenetics and genomics - 1 Apr 2021
Zubiaur Pablo, Saiz-Rodríguez Miriam, Villapalos-García Gonzalo, Navares-Gómez Marcos, Koller Dora, Abad-Santos Francisco
Abstract excerpt
Abacavir (ABC) is an HIV nucleotide-analogue reverse transcriptase inhibitor that can produce a severe hypersensitivity reaction (ABC-HSR) in about 5% of the patients. The HLA-B*57:01 allele is associated with the development of ABC-HSR. Therefore, HLA-B*57:01 genotyping is required prior to the prescription of ABC. The technique routinely used in our laboratory is the sequence-specific oligonucleotide probes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
